Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases

被引:0
|
作者
Dewit, O. [1 ]
机构
[1] St Luc Univ Hosp, Dept Gastroenterol, B-1200 Brussels, Belgium
关键词
azathioprine; 6-thioguanine nucleotides (6-TGN); 6-methylmercaptopurine (6-MMP); thiopurine metabolism; thiopurine side effects; S-METHYLTRANSFERASE; CROHNS-DISEASE; AZATHIOPRINE THERAPY; COST-EFFECTIVENESS; TPMT ACTIVITY; PHARMACOGENETICS; 6-MERCAPTOPURINE; MERCAPTOPURINE; ALLOPURINOL; MYELOSUPPRESSION;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side-effects and inefficacy are a major concern as they lead to withdrawal of the drug. Tools investigating TP metabolism are useful to avoid inadequate cessation of TP therapy. TP metabolism is complex and many enzymes are involved. Among them, Thiopurine methyltransferase (TPMT) is the only one routinely measured by pheno- or genotyping. In this review, the rationale for TPMT and thiopurine metabolites, 6-thioguanine nucleotides and 6-methylmercaptopurine, determination in clinical practice is discussed, specifically in case of thiopurine failure and recommendations are given about their interpretation and potential dose optimization of TP drugs. (Acta gastroenterolog. belg., 2010, 73, 331-335)
引用
收藏
页码:331 / 335
页数:5
相关论文
共 50 条
  • [31] The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease
    Chisick, Laura
    Oleschuk, Curtis
    Bernstein, Charles N.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 27 (01) : 39 - 43
  • [32] Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
    Ansari, A
    Hassan, C
    Duley, J
    Marinaki, A
    Shobowale-Bakre, EM
    Seed, P
    Meenan, J
    Yim, A
    Sanderson, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1743 - 1750
  • [33] Thiopurine metabolite levels correlate with body composition in patients with inflammatory bowel disease
    Holt, D. Q.
    Strauss, B. J.
    Moore, G. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 91 - 91
  • [34] Clinical manifestations of thiopurine S-methyltransferase variants in Korean paediatric patients with inflammatory bowel disease
    Kim, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S304 - S305
  • [35] Thiopurine metabolism monitoring: implications in inflammatory bowel diseases
    Dewit, Olivier
    Starkel, Peter
    Roblin, Xavier
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (11) : 1037 - 1047
  • [36] The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
    Hlavaty, T.
    Batovsky, M.
    Balakova, D.
    Pav, I
    Celec, P.
    Gregus, M.
    Zakuciova, M.
    Hlista, M.
    Horakova, M.
    Desatova, B.
    Koller, T.
    Toth, J.
    Kadasi, L.
    Huorka, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2013, 114 (04): : 199 - 205
  • [37] Allele Frequency of Thiopurine Methyltransferase and Inosine Triphosphate Pyrophosphatase Gene Polymorphisms in Korean Patients with Inflammatory Bowel Diseases
    Cheon, Jae Hee
    Kam, Jae Hak
    Kim, Bo Young
    Kim, Seung Won
    Hong, Sung Yi
    Eun, Chang Soo
    Hong, Seong Soo
    Byeon, Jeong-Sik
    Kim, Tae Il
    Han, Dong Soo
    Yang, Suk-Kyun
    Lee, Kyoung Ryul
    Kim, Won Ho
    HEPATO-GASTROENTEROLOGY, 2009, 56 (90) : 421 - 423
  • [38] Thiopurine-induced pancreatitis in inflammatory bowel diseases
    Ledder, Oren
    Lemberg, Daniel A.
    Day, Andrew S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 399 - 403
  • [39] Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases?
    Frick, Sven
    Mueller, Daniel
    Kullak-Ublick, Gerd A.
    Jetter, Alexander
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (03) : 335 - 342
  • [40] Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases?
    Sven Frick
    Daniel Müller
    Gerd A. Kullak-Ublick
    Alexander Jetter
    European Journal of Clinical Pharmacology, 2019, 75 : 335 - 342